Journal Article

Myelin Basic Protein as a Novel Genetic Risk Factor in Rheumatoid Arthritis—A Genome-Wide Study Combined with Immunological Analyses

Takahashi, Meiko, Ohmura, Koichiro, Yamada, Ryo, Terao, Chikashi, Mimori, Tsuneyo, Matsuda, Fumihiko, Yamamoto, Natsuki, Shimizu, Masakazu, Melchers, Inga, Katayama, Masaki, Shinkura, Reiko, Gut, Ivo, Lathrop, Mark, Toda, Yoshinobu, Kokubo, Miki, Manabe, Toshiaki, Diop, Gora, Heath, Simon

2011

Overview

Rheumatoid arthritis (RA) is a major cause of adult chronic inflammatory arthritis and a typical complex trait. Although several genetic determinants have been identified, they account for only a part of the genetic susceptibility. We conducted a genome-wide association study of RA in Japanese using 225,079 SNPs genotyped in 990 cases and 1,236 controls from two independent collections (658 cases and 934 controls in collection1; 332 cases and 302 controls in collection2), followed by replication studies in two additional collections (874 cases and 855 controls in collection3; 1,264 cases and 948 controls in collection4). SNPs showing p<0.005 in the first two collections and p<10(-4) by meta-analysis were further genotyped in the latter two collections. A novel risk variant, rs2000811, in intron2 of the myelin basic protein (MBP) at chromosome 18q23 showed strong association with RA (p = 2.7×10(-8), OR 1.23, 95% CI: 1.14-1.32). The transcription of MBP was significantly elevated with the risk allele compared to the alternative allele (p<0.001). We also established by immunohistochemistry that MBP was expressed in the synovial lining layer of RA patients, the main target of inflammation in the disease. Circulating autoantibody against MBP derived from human brain was quantified by ELISA between patients with RA, other connective tissue diseases and healthy controls. As a result, the titer of anti-MBP antibody was markedly higher in plasma of RA patients compared to healthy controls (p<0.001) and patients with other connective tissue disorders (p<0.001). ELISA experiment using citrullinated recombinant MBP revealed that a large fraction of anti-MBP antibody in RA patients recognized citrullinated MBP. This is the first report of a genetic study in RA implicating MBP as a potential autoantigen and its involvement in pathogenesis of the disease.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Acids / Alleles / Antibodies - blood / Antibodies - immunology / Antigens / Arthritis / Arthritis, Rheumatoid - genetics / Autoantibodies / Autoimmune diseases / Autoimmunity / Biomarkers / Brain / Case-Control Studies / Chromosome 18 / Citrulline / Collections / Connective tissue diseases / Connective tissues / Consortia / Disease susceptibility / Enzyme-linked immunosorbent assay / Gene Expression Regulation / Genes / Genetic aspects / Genetic Loci - genetics / Genetic Predisposition to Disease - genetics / Genome-wide association studies / Genome-Wide Association Study / Genomes / Genomics / Haplotypes / Health risk assessment / Humans / Immunohistochemistry / Immunology / Inflammation / Male / Medical research / Medicine / Meta-analysis / Metabolism / Myelin / Myelin basic protein / Myelin Basic Protein - genetics / Myelin Basic Protein - immunology / Myelin proteins / Myopia / Pancreatic cancer / Pathogenesis / Patients / Polymorphism, Single Nucleotide - genetics / Population / Reproducibility of Results / Rheumatoid arthritis / Rheumatoid factor / Rheumatology / Risk factors / Single-nucleotide polymorphism / Studies / Synovial Membrane - metabolism / Transcription / Transcription, Genetic / University graduates / Working groups